Live from the NIH registry
Studies recruiting near Beaumont right now
Top 25 of 42 recruiting studies, sorted by proximity — each links to its official registry page
The Golazo® Peripheral Atherectomy System for a Safe and Effective Atherectomy (GREAT Trial)
Peripheral Arterial Disease
N/A
Interventional 159 participants sought
Nextstage Clinical Research - Beaumont — Beaumont, Texas (2.6 mi)
· Sponsor: Nipro Vascular Innovations Americas, Inc
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
Intestinal Neoplasms, Gastrointestinal Neoplasms
Phase 3
Interventional 800 participants sought
Texas Oncology - Gulf Coast — Beaumont, Texas (2.6 mi)
· Sponsor: Pfizer
A Study to Evaluate AZD7760 Safety and Pharmacokinetics in Healthy Adults (Phase I) and Adults With End-stage Kidney Disease on Hemodialysis With a Central Venous Catheter (Phase IIa)
Staphylococcus Aureus
Phase 1, Phase 2
Interventional 231 participants sought
Research Site — Beaumont, Texas (2.6 mi)
· Sponsor: AstraZeneca
Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients
Bipolar Depression
Phase 3
Interventional 384 participants sought
REX Clinical Trials LLC — Beaumont, Texas (2.6 mi)
· Sponsor: Intra-Cellular Therapies, Inc.
A Study of Fruquintinib Plus FOLFIRI as Second-Line Treatment for Participants With Metastatic Colorectal Cancer (FRUITFUL)
Colon Cancer, Rectal Cancer
Phase 2
Interventional 60 participants sought
Texas Oncology - Gulf Coast — Beaumont, Texas (2.6 mi)
· Sponsor: SCRI Development Innovations, LLC
Efficacy in Controlling Myopia in Young Children Using a Novel Spectacle Lens
Myopia, Juvenile Myopia
N/A
Interventional 150 participants sought
Texas State Optical - Dowlen — Beaumont, Texas (2.6 mi)
· Sponsor: SightGlass Vision, Inc.
Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
Carcinoma, Renal Cell, Advanced Renal Cell Carcinoma
Phase 1, Phase 2
Interventional 224 participants sought
Texas Oncology - Gulf Coast — Beaumont, Texas (2.6 mi)
· Sponsor: Pfizer
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
Atrial Fibrillation (AF)
Phase 3
Interventional 2,500 participants sought
Anthos Investigative Site 9913 — Beaumont, Texas (2.6 mi)
· Sponsor: Anthos Therapeutics, Inc.
A Surveillance Study of Susceptibility to Baloxavir Marboxil in Pediatric Participants With Influenza and Transmission of Influenza to Household Contacts
Influenza
Phase 3
Interventional 1,100 participants sought
Tekton Research - Beaumont — Beaumont, Texas (2.6 mi)
· Sponsor: Hoffmann-La Roche
A Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine When Given to Healthy Children 12 to 15 Months of Age
Chickenpox
Phase 3
Interventional 1,840 participants sought
GSK Investigational Site — Beaumont, Texas (2.6 mi)
· Sponsor: GlaxoSmithKline
A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Chronic Inflammatory Demyelinating Polyneuropathy
Phase 3
Interventional 160 participants sought
Gadolin Research - Beaumont- Site Number : 8400047 — Beaumont, Texas (2.6 mi)
· Sponsor: Sanofi
Masupirdine for the Treatment of Agitation in Dementia of the Alzheimer's Type
Agitation, Alzheimer's Type Dementia
Phase 3
Interventional 375 participants sought
Gadolin Research — Beaumont, Texas (2.6 mi)
· Sponsor: Suven Life Sciences Limited
Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma
Asthma
Phase 3
Interventional 440 participants sought
Research Site — Beaumont, Texas (2.6 mi)
· Sponsor: AstraZeneca
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
Chronic Obstructive Pulmonary Disease
Phase 3
Interventional 942 participants sought
REX Clinical Trials - Beaumont- Site Number : 8400014 — Beaumont, Texas (2.6 mi)
· Sponsor: Sanofi
A Safety and Immunogenicity Study of CHIKV VLP Vaccine in Children.
Chikungunya Virus
Phase 3
Interventional 720 participants sought
KidCare Pediatrics — Beaumont, Texas (2.6 mi)
· Sponsor: Bavarian Nordic
A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)
Early Alzheimer's Disease
Phase 2
Interventional 340 participants sought
Gadolin Research ( Site 1032) — Beaumont, Texas (2.6 mi)
· Sponsor: Merck Sharp & Dohme LLC
Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
Urothelial Cancer, Advanced/Metastatic Urothelial Cancer
Phase 1, Phase 2
Interventional 132 participants sought
Texas Oncology - Gulf Coast — Beaumont, Texas (2.6 mi)
· Sponsor: Pfizer
A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.
Depression, Bipolar I Disorder
Phase 3
Interventional 380 participants sought
Beaumont Psychiatric Clinic /ID# 267484 — Beaumont, Texas (2.6 mi)
· Sponsor: AbbVie
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
Non-small Cell Carcinoma, Non-Small Cell Lung Cancer Metastatic
Phase 3
Interventional 680 participants sought
Texas Oncology - Gulf Coast — Beaumont, Texas (2.6 mi)
· Sponsor: Pfizer
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
Lumbar Spinal Stenosis
N/A
Observational 8,000 participants sought
CHRISTUS Southeast Texas -St. Elizabeth — Beaumont, Texas (2.6 mi)
· Sponsor: Stryker Instruments
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
Cardiovascular Disease
Phase 3
Interventional 15,100 participants sought
Research Site — Beaumont, Texas (2.6 mi)
· Sponsor: AstraZeneca
Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
Geographic Atrophy (GA), Age - Related Macular Degeneration (AMD)
Phase 2
Interventional 324 participants sought
Retina Consultants of Texas — Beaumont, Texas (2.6 mi)
· Sponsor: ONL Therapeutics
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)
Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma
Phase 2, Phase 3
Interventional 690 participants sought
Texas Oncology — Beaumont, Texas (2.6 mi)
· Sponsor: Bristol-Myers Squibb
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
Diabetes Mellitus, Type 2, PreDiabetes
N/A
Interventional 7,500 participants sought
Gadolin Research — Beaumont, Texas (2.6 mi)
· Sponsor: Cleerly, Inc.
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
End Stage Kidney Disease
Phase 2, Phase 3
Interventional 3,110 participants sought
MW Clinical Research Center — Beaumont, Texas (2.6 mi)
· Sponsor: CSL Behring